142 related articles for article (PubMed ID: 8781700)
21. Breast cancer: Role of IGF-1 and IGFBP-3 expression in prognostication.
Raval A; Trivedi S
Indian J Exp Biol; 2016 Oct; 54(10):619-629. PubMed ID: 30084561
[TBL] [Abstract][Full Text] [Related]
22. The clinicopathologic and prognostic significance of CD44+/CD24(-/low) and CD44-/CD24+ tumor cells in invasive breast carcinomas.
Mylona E; Giannopoulou I; Fasomytakis E; Nomikos A; Magkou C; Bakarakos P; Nakopoulou L
Hum Pathol; 2008 Jul; 39(7):1096-102. PubMed ID: 18495204
[TBL] [Abstract][Full Text] [Related]
23. Impact of CD44+CD24- cells on non-sentinel axillary lymph node metastases in sentinel node-positive breast cancer.
Nogi H; Suzuki M; Kamio M; Kato K; Kawase K; Toriumi Y; Takeyama H; Fukushima H; Morikawa T; Uchida K
Oncol Rep; 2011 Apr; 25(4):1109-15. PubMed ID: 21308353
[TBL] [Abstract][Full Text] [Related]
24. Expression of c-erbB3 protein in primary breast carcinomas.
Naidu R; Yadav M; Nair S; Kutty MK
Br J Cancer; 1998 Nov; 78(10):1385-90. PubMed ID: 9823984
[TBL] [Abstract][Full Text] [Related]
25. Strong adverse effect of epidermal growth factor receptor 2 overexpression on prognosis of patients with invasive lobular breast cancer: a comparative study with invasive ductal breast cancer in Chinese population.
Wang T; Ma Y; Wang L; Liu H; Chen M; Niu R
Tumour Biol; 2015 Aug; 36(8):6113-24. PubMed ID: 25804795
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of Id-1 is associated with poor clinical outcome in node negative breast cancer.
Schoppmann SF; Schindl M; Bayer G; Aumayr K; Dienes J; Horvat R; Rudas M; Gnant M; Jakesz R; Birner P
Int J Cancer; 2003 May; 104(6):677-82. PubMed ID: 12640673
[TBL] [Abstract][Full Text] [Related]
27. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
[TBL] [Abstract][Full Text] [Related]
28. Characteristics of breast carcinoma cases with false-negative sentinel lymph nodes.
Wei S; Bleiweiss IJ; Nagi C; Jaffer S
Clin Breast Cancer; 2014 Aug; 14(4):280-4. PubMed ID: 24581736
[TBL] [Abstract][Full Text] [Related]
29. Diffuse invasive breast carcinoma of no special type.
Tot T
Virchows Arch; 2016 Feb; 468(2):199-206. PubMed ID: 26521062
[TBL] [Abstract][Full Text] [Related]
30. Distinct hypermethylation profile of primary breast cancer is associated with sentinel lymph node metastasis.
Shinozaki M; Hoon DS; Giuliano AE; Hansen NM; Wang HJ; Turner R; Taback B
Clin Cancer Res; 2005 Mar; 11(6):2156-62. PubMed ID: 15788661
[TBL] [Abstract][Full Text] [Related]
31. Oncotype DX in Bilateral Synchronous Primary Invasive Breast Cancer.
Karsten M; Stempel M; Radosa J; Patil S; King TA
Ann Surg Oncol; 2016 Feb; 23(2):471-6. PubMed ID: 26340863
[TBL] [Abstract][Full Text] [Related]
32. [Expression of adhesive molecule CD44v6 and p53 gene in breast cancer tissues and its relation with DNA ploidy].
Zuo WS; Wei L; Wang XW; Wang YS; Yu ZY
Ai Zheng; 2004 Nov; 23(11 Suppl):1418-22. PubMed ID: 15566648
[TBL] [Abstract][Full Text] [Related]
33. Phenotypic analysis of familial breast cancer: comparison of BRCAx tumors with BRCA1-, BRCA2-carriers and non-familial breast cancer.
Aloraifi F; Alshehhi M; McDevitt T; Cody N; Meany M; O'Doherty A; Quinn CM; Green AJ; Bracken A; Geraghty JG
Eur J Surg Oncol; 2015 May; 41(5):641-6. PubMed ID: 25736863
[TBL] [Abstract][Full Text] [Related]
34. Polymorphisms in cycloxygenase-2 gene and breast cancer prognosis: association between PTGS2 haplotypes and histopathological features.
Festa-Vasconcellos JS; Piranda DN; Amaral LM; Indio-do-Brasil V; Koifman S; Vianna-Jorge R
Breast Cancer Res Treat; 2012 Feb; 132(1):251-8. PubMed ID: 22037828
[TBL] [Abstract][Full Text] [Related]
35. Soluble CD44 splice variants in metastasizing human breast cancer.
Martin S; Jansen F; Bokelmann J; Kolb H
Int J Cancer; 1997 Aug; 74(4):443-5. PubMed ID: 9291436
[TBL] [Abstract][Full Text] [Related]
36. Metastatic potential of T1 breast cancer can be predicted by the 70-gene MammaPrint signature.
Mook S; Knauer M; Bueno-de-Mesquita JM; Retel VP; Wesseling J; Linn SC; Van't Veer LJ; Rutgers EJ
Ann Surg Oncol; 2010 May; 17(5):1406-13. PubMed ID: 20094918
[TBL] [Abstract][Full Text] [Related]
37. Role of CD44 in nonpalpable T1a and T1b breast cancer.
Lyzak JS; Yaremko ML; Recant W; Baunoch DA; Joseph L
Hum Pathol; 1997 Jul; 28(7):772-8. PubMed ID: 9224743
[TBL] [Abstract][Full Text] [Related]
38. Bcl-2 expression is associated with lymph node metastasis in human ductal breast carcinoma.
Sierra A; Lloveras B; Castellsagué X; Moreno L; García-Ramirez M; Fabra A
Int J Cancer; 1995 Jan; 60(1):54-60. PubMed ID: 7814152
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathologic features predicting involvement of non- sentinel axillary lymph nodes in Iranian women with breast cancer.
Moosavi SA; Abdirad A; Omranipour R; Hadji M; Razavi AE; Najafi M
Asian Pac J Cancer Prev; 2014; 15(17):7049-54. PubMed ID: 25227789
[TBL] [Abstract][Full Text] [Related]
40. The role of angiogenesis, laminin and CD44 expression in metastatic behavior of early-stage low-grade invasive breast carcinomas.
Ozer E; Canda T; Kurtodlu B
Cancer Lett; 1997 Dec; 121(2):119-23. PubMed ID: 9570348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
